Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Danielle Nina Margalit, M.D.

Concepts (245)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Head and Neck Neoplasms33202428814.350 Why?
Oropharyngeal Neoplasms1420244914.190 Why?
Carcinoma, Squamous Cell19202440192.500 Why?
Papillomavirus Infections11202416021.870 Why?
Papillomaviridae9202411201.690 Why?
Carcinoma, Merkel Cell420223211.680 Why?
Radiotherapy, Intensity-Modulated820228001.560 Why?
Radium32022721.060 Why?
Neoplasm Recurrence, Local17202492450.720 Why?
Skin Neoplasms6202357980.690 Why?
Neoadjuvant Therapy4202428090.580 Why?
Granuloma, Plasma Cell12018800.570 Why?
Financial Management120181600.550 Why?
Mouth Diseases120182380.510 Why?
Neoplasm Staging102024110820.490 Why?
Radiotherapy Dosage8202328940.480 Why?
Tooth Diseases12015740.480 Why?
Carcinoma, Adenoid Cystic320212620.460 Why?
Radiation Oncology220175590.430 Why?
SEER Program4202014540.410 Why?
Superoxide Dismutase120155920.400 Why?
Mouth Neoplasms320245930.390 Why?
Receptor Protein-Tyrosine Kinases1201816230.360 Why?
beta Carotene120115230.350 Why?
Neoplasms, Second Primary3202310510.330 Why?
Leadership1201813710.320 Why?
Osteoradionecrosis22020510.310 Why?
Humans7020247575660.300 Why?
Receptors, Progesterone1201211290.290 Why?
Radiotherapy Planning, Computer-Assisted4202316590.290 Why?
Lymph Nodes2201834700.290 Why?
Mastectomy, Segmental120129720.280 Why?
Prostatic Neoplasms42020110570.240 Why?
Radiotherapy1201114980.230 Why?
Receptors, Estrogen1201222080.230 Why?
Mastectomy1201218340.230 Why?
Antioxidants1201116650.220 Why?
Aged2720241678900.220 Why?
Quality of Life22022132630.220 Why?
Receptor, erbB-22202025520.220 Why?
Medical Errors1201112550.210 Why?
Middle Aged2820242191920.210 Why?
Aged, 80 and over162024585580.210 Why?
Clinical Trials as Topic1201879820.200 Why?
Rectal Neoplasms1201111540.200 Why?
Combined Modality Therapy5202385120.200 Why?
Tonsillar Neoplasms12021500.190 Why?
Antineoplastic Agents32020135970.190 Why?
Radiotherapy, Adjuvant3202017880.180 Why?
Retrospective Studies172024799840.180 Why?
Male3220243581800.180 Why?
Societies, Medical2202338870.170 Why?
Radiation Dosage3202319570.170 Why?
Kaplan-Meier Estimate3202064700.170 Why?
Female3020243899430.170 Why?
Lung Neoplasms12023132680.160 Why?
Cytoskeletal Proteins1200413420.160 Why?
Dental Porcelain12018680.160 Why?
Osteonecrosis120202290.150 Why?
Dental Materials120181130.150 Why?
Sarcopenia120233720.150 Why?
Hypokalemia120191520.150 Why?
Palate, Hard12018580.150 Why?
Mucositis120191080.150 Why?
Disease-Free Survival5202168070.150 Why?
Neoplasms, Unknown Primary120191020.150 Why?
Radiotherapy, Conformal220115490.150 Why?
Oropharynx120181330.150 Why?
Neck120227310.140 Why?
Chemotherapy, Adjuvant2202435100.140 Why?
Peer Review, Health Care12017730.140 Why?
Carotid Stenosis120248530.140 Why?
Maximum Tolerated Dose120198770.140 Why?
Salivary Gland Neoplasms120203040.130 Why?
Treatment Outcome112021642420.130 Why?
Hyperbaric Oxygenation120171650.130 Why?
Lymphatic Metastasis2201529140.130 Why?
Dental Care120192780.130 Why?
Asymptomatic Diseases120185840.120 Why?
Prognosis62024294880.120 Why?
Genetic Association Studies2201527170.120 Why?
Proportional Hazards Models42019123970.120 Why?
Postoperative Period1201918060.120 Why?
Protons1201911120.110 Why?
Enzyme Inhibitors1200437090.110 Why?
Immunocompromised Host120198540.110 Why?
Incidence32024212170.110 Why?
Adenocarcinoma1201163230.110 Why?
Cancer Care Facilities220194190.110 Why?
Prospective Studies72020540920.110 Why?
Fatal Outcome1201818280.110 Why?
Survival Analysis42020100750.110 Why?
Sentinel Lymph Node Biopsy120187350.110 Why?
Bone Density Conservation Agents120207920.110 Why?
Leg1201810880.100 Why?
Adult1620242197250.100 Why?
Saliva120178200.100 Why?
Diarrhea1201913170.100 Why?
Antineoplastic Combined Chemotherapy Protocols32024117090.100 Why?
Survivors1202223700.100 Why?
Carcinoma1202323300.100 Why?
Class I Phosphatidylinositol 3-Kinases120168960.100 Why?
Radiation Injuries1201911840.090 Why?
United States52023719020.090 Why?
Endoribonucleases120132280.090 Why?
Drug Administration Schedule1201948450.090 Why?
Bacterial Proteins1200438240.090 Why?
Palatine Tonsil220211930.090 Why?
Consensus1202030970.090 Why?
Breast Neoplasms22020209920.090 Why?
Axilla120126260.080 Why?
Young Adult62020587550.080 Why?
Recurrence2202084260.080 Why?
Immunoenzyme Techniques1201217040.080 Why?
Radiation Tolerance120114790.080 Why?
Neoplasms12018219860.080 Why?
Killer Cells, Natural1201822000.080 Why?
Quality Control120118250.080 Why?
Documentation120158920.080 Why?
Medical Oncology1202023080.080 Why?
Proto-Oncogene Proteins p21(ras)1201617280.070 Why?
Pyrazoles1201819920.070 Why?
Multiple Sclerosis1202232020.070 Why?
Organs at Risk220223580.070 Why?
Silent Information Regulator Proteins, Saccharomyces cerevisiae12007630.070 Why?
Prostatectomy2201318210.070 Why?
Practice Guidelines as Topic2202473660.070 Why?
Hospitalization22020106340.070 Why?
Germ-Line Mutation1201518410.070 Why?
Lymph Node Excision1201212770.070 Why?
Pyridines1201828640.070 Why?
Confidence Intervals1201129220.060 Why?
Quality Assurance, Health Care2201721670.060 Why?
Antibodies, Viral1201731460.060 Why?
Carcinoma, Intraductal, Noninfiltrating120129350.060 Why?
Patient Education as Topic1201523060.060 Why?
CD8-Positive T-Lymphocytes1201845500.060 Why?
Early Detection of Cancer1201931640.060 Why?
Neoplasm Invasiveness1201235910.060 Why?
Genomics1202057880.060 Why?
Sirtuins120073200.060 Why?
Cisplatin2202016470.060 Why?
Biopolymers120041840.060 Why?
Neoplasm Metastasis3202048860.050 Why?
Palliative Care1201835680.050 Why?
Survival Rate22017126840.050 Why?
Coronavirus Infections1202030770.050 Why?
Histone Deacetylases120077180.050 Why?
Pneumonia, Viral1202031970.050 Why?
Gene Expression Regulation, Neoplastic1201885030.050 Why?
Registries1201881640.050 Why?
Prostate-Specific Antigen1201124560.050 Why?
Protein Kinase Inhibitors1201856380.050 Why?
Diagnostic Imaging1201535240.050 Why?
Cohort Studies42020411900.050 Why?
Parotid Gland120221750.050 Why?
Logistic Models22017132210.050 Why?
Cause of Death1201136670.050 Why?
Retreatment120225960.040 Why?
Pandemics1202086000.040 Why?
Risk Factors42024737080.040 Why?
Diagnosis, Differential12015129510.040 Why?
Bone Neoplasms1201125240.040 Why?
Community Medicine12019230.040 Why?
Dental Alloys12018290.040 Why?
Drug Evaluation, Preclinical1200413340.040 Why?
Tomography, X-Ray Computed22023204990.040 Why?
Odds Ratio1201196240.040 Why?
Structure-Activity Relationship1200430690.040 Why?
Follow-Up Studies32019390200.040 Why?
Predictive Value of Tests12015152070.040 Why?
Boston1201192980.040 Why?
Tongue120214030.040 Why?
Androgen Antagonists2202014000.040 Why?
Zirconium120181070.040 Why?
Polymorphism, Single Nucleotide22015157740.040 Why?
Electronic Health Records1201547600.040 Why?
Double-Blind Method12011122610.040 Why?
Dentists120191770.040 Why?
Dental Prosthesis Design120182640.040 Why?
Jaw12017930.030 Why?
Protein Conformation1200439660.030 Why?
Cyclin-Dependent Kinase Inhibitor p1812016520.030 Why?
Saccharomyces cerevisiae1200726850.030 Why?
Tumor Burden1202118860.030 Why?
Mucous Membrane120196570.030 Why?
Materials Testing120188600.030 Why?
Smoking1201290360.030 Why?
Polymerase Chain Reaction1202460700.030 Why?
Salvage Therapy1202112630.030 Why?
Multivariate Analysis22019120470.030 Why?
Age Factors12011183260.030 Why?
Nutrition Surveys1202117160.030 Why?
Cyclin D1120164510.030 Why?
Oral Health120194840.030 Why?
Mycobacterium tuberculosis1200419030.030 Why?
Receptor, Notch1120164940.030 Why?
Cyclin-Dependent Kinase Inhibitor p16120166970.030 Why?
Escherichia coli1200442150.020 Why?
Adaptation, Psychological1202226290.020 Why?
Antibody Formation1201613970.020 Why?
Immunity, Cellular1201615570.020 Why?
Risk Assessment22024238160.020 Why?
Immunologic Factors1201915840.020 Why?
DNA1202272000.020 Why?
Patient Compliance1201926850.020 Why?
Anxiety1202245320.020 Why?
Chronic Disease1202292630.020 Why?
Organisms, Genetically Modified12007630.020 Why?
Hematologic Neoplasms1201918900.020 Why?
Adolescent12015878190.020 Why?
Sirtuin 212007950.020 Why?
Genetic Complementation Test120075550.020 Why?
Anti-Bacterial Agents1200473990.020 Why?
Tumor Suppressor Protein p531201629130.020 Why?
Base Sequence12016124370.010 Why?
Prostate1201317570.010 Why?
Antineoplastic Agents, Hormonal1201315160.010 Why?
Reproducibility of Results12022200370.010 Why?
Decision Making1201839090.010 Why?
Neoplasm Proteins1201636080.010 Why?
Quality Improvement1201937930.010 Why?
High-Throughput Nucleotide Sequencing1201636140.010 Why?
Analysis of Variance1201262300.010 Why?
Interleukin-61201332060.010 Why?
Algorithms12023139520.010 Why?
Stroke1202496950.010 Why?
Chromosomal Proteins, Non-Histone120077260.010 Why?
Cross-Sectional Studies12022259240.010 Why?
Cytokines1201673360.010 Why?
C-Reactive Protein1201338090.010 Why?
Gene Silencing1200715070.010 Why?
Gene Expression Profiling1201694030.010 Why?
Gene Deletion1200726660.010 Why?
DNA-Binding Proteins1201695740.010 Why?
Genotype12013129510.010 Why?
Sex Factors12012104950.010 Why?
Phosphoproteins1200724320.010 Why?
Saccharomyces cerevisiae Proteins1200718400.010 Why?
Alleles1200768940.010 Why?
Cell Cycle Proteins1200734340.010 Why?
Protein Binding1200793120.010 Why?
Inflammation12013107090.010 Why?
HIV Infections12019172700.010 Why?
Nuclear Proteins1200757860.010 Why?
Margalit's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (245)
Explore
_
Co-Authors (97)
Explore
_
Similar People (59)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.